Merit Medical Systems, Inc. (MMSI)
Merit Medical: Undervalued With Multiple Growth Drivers In Play
Merit Medical has shown solid performance with revenue and EBITDA growth, but has only tracked the broader med-tech market higher as investors wait for more exciting drivers. The company's WRAPSODY endovascular stent graft has potential to exceed management's projections, and could be a practice-changing $100M+ product with good clinical data. Merit's December 2023 convertible debt offering was well in excess of corporate needs, which leads me to believe that M&A is back on the table.
Merit Medical recalling plastic syringes supplied by Jiangsu Shenli Medical, US FDA says
The U.S. Food and Drug Administration said on Friday that Merit Medical Systems has initiated a recall for plastic syringes supplied by Jiangsu Shenli Medical Production.
Here's Why Merit Medical (MMSI) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Merit Medical (MMSI) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Merit Medical (MMSI) Up 5% Since Last Earnings Report: Can It Continue?
Merit Medical (MMSI) reported earnings 30 days ago. What's next for the stock?
Why Merit Medical (MMSI) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Merit Medical's (MMSI) Latest Launch to Boost Patient Care
Merit Medical's (MMSI) latest offering is likely to create an efficient approach to inflation, thereby providing improved patient care.
Three Reasons to Retain Merit Medical (MMSI) Stock for Now
Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.
